(Q48266484)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17314920%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17314920%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17314920%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

5

Heinrich Sauer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17314920%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1

Stefan Smesny

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17314920%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Kati Baur

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17314920%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Nicole Rudolph

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17314920%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

21 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17314920%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17314920%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17314920%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17314920%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

2067-2073

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17314920%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301343

26 December 2019

exact match

0 references

cites work

Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

The Membrane Binding of Morphine, Diphenylhydantoin, and Tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Causal association between cannabis and psychosis: examination of the evidence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

G-protein mediation of cannabinoid-induced phospholipase activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Implications of lipid biology for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Phospholipase participation in cannabinoid-induced release of free arachidonic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Oxidative metabolism of anandamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Prevalence of substance misuse in first-episode psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Cannabis and schizophrenia: results of a follow-up study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9-Tetrahydrocannabinol-Tolerant Rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

The intracellular localization of Δ9-tetrahydrocannabinol in liver and its effects on drug metabolism in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Cannabis use predicts future psychotic symptoms, and vice versa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Increased platelet phospholipase A2 activity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

The role of cannabinoids in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Membrane fatty acids, niacin flushing and clinical parameters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

The endophenotype concept in psychiatry: etymology and strategic intentions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Cannabis use and outcome of recent onset psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

The environment and schizophrenia: the role of cannabis use.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Effects of cannabinoids on the activities of mouse brain lipases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Psychiatric effects of cannabis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Changes induced by hashish constituents on human erythrocyte phospholipids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

The significance of lymphocyte lipid changes after smoking hashish

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Effects of Δ9-THC on human platelet phospholipids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Interpretive risks: the use of the Hopkins Symptom Checklist 90-Revised (SCL 90-R) with brain tumour patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Cerebral phosphate metabolism in first-degree relatives of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Drug and alcohol problems among individuals with severe mental illness in south London

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Relationship between the niacin skin flush response and essential fatty acids in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Cannabis use and mental health in young people: cohort study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Environmental factors and membrane polyunsaturated fatty acids in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Long-term cannabis use: characteristics of users in an Australian rural area

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Cannabis use is associated with schizotypy and attentional disinhibition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Prostaglandin-mediated signaling in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Potential use of the topical niacin skin test in early psychosis -- a combined approach using optical reflection spectroscopy and a descriptive rating scale.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Increased phospholipase A2 activity in schizophrenia with absent response to niacin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Co-distribution of sensory gating and impaired niacin flush response in the parents of schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Potential diagnostic aids for abnormal fatty acid metabolism in a range of neurodevelopmental disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021

Exploring the relationship between cannabis use and psychosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301343

7 January 2021